Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

1,264 public trials 216 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Recruiting

CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

NCT06208735

Conditions
B-cell Acute Lymphoblastic Leukemia, B-cell Leukemia, B-cell Lymphoma, +28 more
Locations
  • Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
  • Alberta Children's Hospital Calgary, Alberta, Canada
  • Vancouver General Hospital Vancouver, British Columbia, Canada
  • BC Children's Hospital Vancouver, British Columbia, Canada
View Trial Details
Recruiting

DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)

NCT07059650

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Peking University Third Hospital Beijing, China
  • Hunan Cancer Hospital Changsha, China
  • West China Hospital of Sichuan University Chengdu, China
  • Guangdong Provincial People's Hospital Guangzhou, China
View all 13 locations
View Trial Details
Recruiting

NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)

NCT07502118

Conditions
Burkitt Lymphoma, Cytokine Release Syndrome, DNA Virus Infections, +29 more
Locations
  • Ankara Bilkent City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)
  • Ankara Etlik City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)
  • Hacettepe University Faculty of Medicine - Department of Internal Medicine, Division of Hematology Ankara, Turkey (Türkiye)
  • University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Ankara, Turkey (Türkiye)
View Trial Details

Related conditions